Xu H - Search Results

1

[Recent advances in the study of cleavable PEG-lipid derivatives modifying liposomes].

Xu H, Deng YH, Chen DW. Xu H, et al. Yao Xue Xue Bao. 2008 Jan;43(1):18-22. Yao Xue Xue Bao. 2008. PMID: 18357726 Review. Chinese.

2

Preparation and characterization of pH-sensitive vesicles made of cholesteryl hemisuccinate.

Xu H, Deng Y, Chen D, Qin J, Liu J, Shi L, Lu Y. Xu H, et al. Drug Dev Ind Pharm. 2008 Feb;34(2):134-41. doi: 10.1080/03639040701410903. Drug Dev Ind Pharm. 2008. PMID: 18302031

3

Preparation, characterization, and evaluation of liposomal ferulic acid in vitro and in vivo.

Qin J, Chen D, Lu W, Xu H, Yan C, Hu H, Chen B, Qiao M, Zhao X. Qin J, et al. Among authors: xu h. Drug Dev Ind Pharm. 2008 Jun;34(6):602-8. doi: 10.1080/03639040701833559. Drug Dev Ind Pharm. 2008. PMID: 18568910

4

Esterase-catalyzed dePEGylation of pH-sensitive vesicles modified with cleavable PEG-lipid derivatives.

Xu H, Deng Y, Chen D, Hong W, Lu Y, Dong X. Xu H, et al. J Control Release. 2008 Sep 24;130(3):238-45. doi: 10.1016/j.jconrel.2008.05.009. Epub 2008 May 17. J Control Release. 2008. PMID: 18657874

5

[Recent advances in the study of accelerated blood clearance phenomenon of PEGylated liposomes].

Xu H, Wang KQ, Huang WW, Deng YH, Chen DW. Xu H, et al. Yao Xue Xue Bao. 2010 Jun;45(6):677-83. Yao Xue Xue Bao. 2010. PMID: 20939173 Review. Chinese.

6

Preparation and characterization of stable pH-sensitive vesicles composed of α-tocopherol hemisuccinate.

Xu H, Deng YH, Wang KQ, Chen DW. Xu H, et al. AAPS PharmSciTech. 2012 Dec;13(4):1377-85. doi: 10.1208/s12249-012-9863-7. Epub 2012 Oct 3. AAPS PharmSciTech. 2012. PMID: 23054989 Free PMC article.

7

Influence of phospholipid types and animal models on the accelerated blood clearance phenomenon of PEGylated liposomes upon repeated injection.

Xu H, Ye F, Hu M, Yin P, Zhang W, Li Y, Yu X, Deng Y. Xu H, et al. Drug Deliv. 2015;22(5):598-607. doi: 10.3109/10717544.2014.885998. Epub 2014 Feb 13. Drug Deliv. 2015. PMID: 24524364 Free article.

8

["PEG dilemma" for liposomes and its solving approaches].

Zhang D, Xu H, Hu MN, Deng YH. Zhang D, et al. Among authors: xu h. Yao Xue Xue Bao. 2015 Mar;50(3):252-60. Yao Xue Xue Bao. 2015. PMID: 26118102 Review. Chinese.

9

[Preparation and evaluation of doxorubicin hydrochloride liposomes modified by poly(2-ethyl-2-oxazoline)-cholesteryl methyl carbonate].

Zhang D, Li JY, Wang XC, Yue HX, Hu MN, Yu X, Xu H. Zhang D, et al. Among authors: xu h. Yao Xue Xue Bao. 2015 Sep;50(9):1174-9. Yao Xue Xue Bao. 2015. PMID: 26757556 Chinese.

10

Effects of cleavable PEG-cholesterol derivatives on the accelerated blood clearance of PEGylated liposomes.

Xu H, Wang KQ, Deng YH, Chen DW. Xu H, et al. Biomaterials. 2010 Jun;31(17):4757-63. doi: 10.1016/j.biomaterials.2010.02.049. Epub 2010 Mar 19. Biomaterials. 2010. PMID: 20303164

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

45,761 results

Search Page

Filters